Bendamustine (Treanda) for CLL and NHL
Bendamustine HCl (Treanda - Cephalon), an unusual DNA-alkylating agent that has been used in Europe for many years to treat lymphoma, has now been approved by the FDA for treatment of chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Bendamustine (Treanda) for CLL and NHL
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1299
Article Code: 1299c
Date: November 17, 2008
Volume: 50
Pages: 91-92
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1299
Article Code: 1299c
Date: November 17, 2008
Volume: 50
Pages: 91-92
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)
